An overview of the diagnosis and pharmacologie treatment of migraine

Mayo Clinic Proceedings

Volumn 71, Issue 11, 1996, Pages 1055-1066

  Capobianco, David J ^a   Cheshire, William P ^a   Keith Campbell, J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; BUTALBITAL; BUTORPHANOL; CAFFEINE; CHLORPROMAZINE; DICHLORALPHENAZONE; DIHYDROERGOTAMINE; ERGOTAMINE TARTRATE; HYDROCORTISONE; IBUPROFEN; INDOMETACIN; KETOROLAC; METHYLPREDNISOLONE; METOCLOPRAMIDE; NAPROXEN; PARACETAMOL; PETHIDINE; PREDNISONE; PROCHLORPERAZINE; SUMATRIPTAN;

ANALGESIC ACTIVITY; ARTICLE; DIAGNOSTIC APPROACH ROUTE; DROWSINESS; DRUG BIOAVAILABILITY; DRUG CHOICE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER TOXICITY; MIGRAINE; NEPHROTOXICITY; PATIENT COUNSELING; PATIENT EDUCATION; RISK ASSESSMENT; RISK FACTOR; THORAX PAIN; TREATMENT PLANNING; VERTIGO;

EID: 0030317779     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/71.11.1055     Document Type: Article

References (72)

1. Stewart WF, Lipton RB, Celentano DD, Reed ML, Prevalence of migraine headache in the United States: relation to age, income, race, and other sociodemographic factors, JAMA 1992; 267:64-69
2. Lipton RB, Stewart WF, Migraine in the United States: a review of epidemiology and health care use, Neurology 1993; 43(Suppl 3):S6-S10
3. Stang PE, Osterhaus JT, Celentano DD, Migraine: patterns of healthcare use, Neurology 1994; 44(Suppl 4):S47-S55
4. Osterhaus JT, Gutterman DG, Plachetka JR, Healthcare resource and lost labor costs of migraine headache in the United States, Pharmacoeconomics 1992; 2:67-76
5. RaskinNH, On the origin of head pain, Headache 1988; 28:254-257
6. Silberstein SD, Advances in understanding the pathophysiology of headache, Neurology 1992; 42(Suppl 2):6-10
7. Lance JW, Current concepts of migraine pathogenesis, Neurology 1993;43(Suppl3):Sll-S15
8. Goadsby PJ, Gundlach AL, Localization of 3H-dihydroergotaminebinding sites in the cat central nervous system: relevance to migraine, Ann Neurol 1991; 29:91-94
9. Weiller C, May A, Limmroth V, Juptner M, Kaube H, Schayck RV, et al, Brain stem activation in spontaneous human migraine attacks, Nature Med 1995; 1:658-660
10. Silberstein SD, Serotonin (5-HT) and migraine, Headache 1994; 34:408-417
11. Moskowitz MA, The neurobiology of vascular head pain, Ann Neurol 1984; 16:157-168
12. Headache Classification Committee of the International Headache Society, Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, Cephalalgia 1988; 8(Suppl 7): 1-96
13. RaskinNH, Diagnosis and treatment of migraine: update on headache; a comprehensive course in mechanisms and management, Presented at the Scottsdale Headache Symposium of the American Association for the Study of Headache; 1995 Jan 20-22; Scottsdale (AZ)
14. Edmeads J, Headache, 4th ed. Dorval (Quebec): Sandoz Canada, 1992
15. Blau JN, Migraine prodromes separated from the aura: complete migraine, BMJ 1980; 281:658-660
16. Campbell JK, Manifestations of migraine, Neurol Clin 1990Nov; 8:841-855
17. Silberstein SD, Lipton RB, Overview of diagnosis and treatment of migraine, Neurology 1994; 44(Suppl 7):S6-S16
18. Lance JW, Mechanism and Management of Headache, 5th ed. Boston: Butterworth-Heinemann, 1993
19. Campbell JK, Caselli RJ, Headache and other craniofacial pain, In: Bradley WG, Daroff RB, Fenichel CM, Marsden CD, editors. Neurology in Clinical Practice. Vol 2. 2nd ed. Boston: ButterworthHeinemann, 1996: 1683-1719
20. Mathew NT, Kurman R, Perez F, Drug induced refractory headache-clinical features and management, Headache 1990; 30:634638
21. RaskinNH, Acute and prophylactic treatment of migraine: practical approaches and pharmacologie rationale, Neurology 1993;43(Suppl 3):S39-S42
22. Welch KMA, Drug therapy of migraine, N EngI J Med 1993; 329:1476-1483
23. Ryan RE, A study of midrin in the symptomatic relief of migraine headache, Headache 1974; 14:33-42
24. Nestvold K, Kloster R, Partinen M, Sulkava R, Treatment of acute migraine attack: naproxen and placebo compared, Cephalalgia 1985; 5:115-119
25. Havanka-Kanniainen H, Treatment of acute migraine attack: ibuprofen and placebo compared, Headache 1989; 29:507-509
26. Klapper JA, Stanton JS, Ketorolac versus DHE and metoclopramide in the treatment of migraine headaches, Headache 1991:31:523-524
27. Saadah HA, Abortive migraine therapy with oral naproxen sodium plus metoclopramide plus ergotamine tartrate with caffeine. Headache 1992; 32:95-97
28. Quality Standards Subcommittee of the American Academy of Neurology, Practice parameter: appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Neurology 1995; 45:585-587
29. Perrin VL, Clinical pharmacokinetics of ergotamine in migraine and cluster headache. Clin Pharmacokinet 1985; 10:334-352
30. Sanders SW, Haering N, Mosberg H, Jaeger H, Pharmacokinetics of ergotamine in healthy volunteers following oral and rectal dosing. Eur J Clin Pharmacol 1986; 30:331 -334
31. Horton BT, Peters GA, Blumenthal LS, A new product in the treatment of migraine: a preliminary report. Mayo Clin Proc 1945; 20:241-248
32. Callaham M, Raskin N, A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache 1986; 26:168171
33. Winner P, Dalessio D, Mathew N, Sadowsky C, Turkewitz LJ, Sheftell F, et al, Office-based treatment of acute migraine with dihydroergotamine mesylate. Headache 1993; 33:471-475
34. Raskin NH, Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology 1986; 36:995-997
35. Cady RK, Wendt JK, Kirchner JR, Sargent JD, Rothrock JF, Skaggs H Jr, Treatment of acute migraine with subcutaneous sumatriptan. JAMA 1991; 265:2831-2835
36. Subcutaneous Sumatriptan International Study Group, Treatment of migraine attacks with sumatriptan. NEnglJMed 1991; 325:316-321
37. Bates D, Ashford E, Dawson R, Ensink FB, Gilhus NE, Olesen J, et al (for the Sumatriptan Aura Study Group), Subcutaneous sumatriptan during the migraine aura. Neurology 1994; 44:1587-1592
38. Oral Sumatriptan International Multiple-Dose Study Group, Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 1991 ; 31:306-313
39. Edmeads J, Advances in migraine therapy: focus on oral sumatriptan. Neurology 1995; 45(Suppl 7):S3-S4
40. Hillis WS, MacIntyrePD, Sumatriptan and chest pain. Lancet 1993; 341:1564-1565
41. Diamond S, The use of sumatriptan in patients on monoamine oxidase inhibitors [editorial]. Neurology 1995; 45:1039-1040
42. Bell R, Montoya D, Shuaib A, Lee MA, A comparative trial of three agents in the treatment of acute migraine headache. Ann Emerg Med 1990; 19:1079-1082
43. Jones J, Sklar D, Dougherty J, White W, Randomized double-blind trial of intravenous prochlorperazine for the treatment of acute headache. JAMA 1989; 261:1174-1176
44. GallagherRM, Emergency treatment of intractable migraine. Headache 1986; 26:74-75
45. Campbell JK, Zagami A, Status migrainosus. In: Olesen J, TfeltHansen P, Welch KMA, editors. The Headaches. New York: Raven Press, 1993:405-407
46. Olesen J, A review of current drugs for migraine. J Neurol 1991; 238(Suppl 1):S23-S27
47. Hoffen MJ, Couch JR, Diamond S, Elkind AH, Goldstein J, Kohlerman NJ, et al, Transnasal butorphanol in the treatment of acute migraine. Headache 1995; 35:65-69
48. Diener H-C, Limmroth V, The treatment of migraine. Rev Contemp Pharmacother 1994; 5:271-284
49. Diamond S, Medina JL, Double blind study of propranolol for migraine prophylaxis. Headache 1976; 16:24-27
50. Nadelman JW, Phil M, Stevens J, Saper JR, Propranolol in the prophylaxis of migraine. Headache 1986; 26:175-182
51. Ryan RE Sr, Ryan RE Jr, Sudilovsky A, Nadolol: its use in the prophylactic treatment of migraine. Headache 1983; 23:26-31
52. Stensrud P, Sjaastad O, Comparative trial of Tenormin (atenolol) and Inderal (propranolol) in migraine. Headache 1980; 20:204207
53. Stellar S, Ahrens SP, Meibohm AR, Reines SA, Migraine prevention with timolol: a double-blind crossover study. JAMA 1984; 252:2576-2580
54. Kangasniemi P, Hedman C, Metoprolol and propranolol in the prophylactic treatment of classical and common migraine: a doubleblind study. Cephalalgia 1984; 4:91-96
55. Solomon GD, Steel JG, Spaccavento LJ, Verapamil prophylaxis of migraine: a double-blind, placebo-controlled study. JAMA 1983; 250:2500-2502
56. Markley HG, Cheronis JC, Piepho RW, Verapamil in prophylactic therapy of migraine. Neurology 1984; 34:973-976
57. Couch JR, Hassanein RS, Arnitriptyline in migraine prophylaxis. ArchNeurol 1979; 36:695-699
58. Ziegler DK, Hurwitz A, Preskorn S, Hassanein R, Seim J, Propranolol and amitriptyline in prophylaxis of migraine: pharmacokinetic and therapeutic effects. ArchNeurol 1993; 50:825-830
59. Jensen R, Brinck T, Olesen J, Sodium valproate has a prophylactic effect in migraine without aura: a triple-blind, placebo-controlled crossover study. Neurology 1994; 44:647-651
60. Mathew NT, Saper JR, Silberstein SD, Rankin L, Markley HG, Solomon S, et al, Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281-286
61. Silberstein SD, Wilmore LJ, Divalproex sodium: migraine treatment and monitoring. Headache 1996; 36:239-242
62. Sicuteri F, Prophylactic and therapeutic properties of 1-methyllysergic acid butanolamide in migraine: preliminary report. Int Arch Allergy 1959; 15:300-307
63. Curran DA, Lance JW, Clinical trial of methysergide and other preparations in the management of migraine. J Neurol Neurosurg Psychiatry 1964; 27:463-469
64. Pedersen E, Moller CE, Methysergide in migraine prophylaxis. Clin Pharmacol Ther 1966; 4:520-526
65. Physicians' Desk Reference, 49th ed. Montvale (NJ): Medical Economics Data Production Company, 1995
66. Miiller-Schweinitzer E, Tapparelli C, Methylergometrine, an active metabolite of methysergide. Cephalalgia 1986; 6:35-41
67. Mathew NT, Indomethacin responsive headache syndromes. Headache 1981; 21:147-150
68. Anthony M, Lance JW, Monoamine oxidase inhibition in the treatment of migraine. ArchNeurol 1969; 21:263-268
69. O'Neill BP, Mann JD, Aspirin prophylaxis in migraine. Lancet 1978; 2:1179-1181
70. Stieg RL, Double-blind study of belladonna-ergotaminephenobarbital for interval treatment of recurrent throbbing headache. Headache 1977; 17:120-124
71. Adly C, Straumanis J, Chesson A, Fluoxetine prophylaxis of migraine. Headache 1992; 32:101-104
72. Vijayan N, Brief therapeutic report: papaverine prophylaxis of complicated migraine. Headache 1977; 17:159-162